Management of Denosumab Therapy in Patients Undergoing Deep Dental Work

Pre-Treatment Protocol

All patients should undergo a mandatory dental examination with preventive dentistry before initiating denosumab therapy, as recommended by the National Comprehensive Cancer Network 1, 2
Complete any planned invasive dental procedures (extractions, implants) before starting denosumab whenever possible, to eliminate the elevated ONJ risk entirely, as suggested by the Annals of Oncology 3

Additional risk factors for ONJ include concurrent chemotherapy, corticosteroid use, poor oral hygiene, periodontal disease, and dental abscess, according to the National Comprehensive Cancer Network 1, 2
Unlike bisphosphonates, denosumab does not accumulate in bone and has no prolonged duration of action, meaning its antiresorptive effects are fully reversible within months of the last dose, as reported in the Annals of Oncology 3

Prophylactic antibiotics are advised when tooth extraction cannot be avoided in patients on denosumab, as recommended by the Annals of Oncology 3
Suspend denosumab until healing of the tooth socket appears complete, which typically requires clinical and radiographic confirmation, as suggested by the Annals of Oncology 3

The overall incidence of ONJ with denosumab remains low (1-3%) even with long-term use, but vigilance is essential, according to the Journal of the National Comprehensive Cancer Network 5
For patients requiring urgent dental surgery who cannot wait 6-7 months, consider transitioning to a bisphosphonate before the procedure, though this requires careful planning given denosumab's rebound effect, as reported in the Annals of Oncology 3
In patients with renal disease where bisphosphonates are contraindicated, the risk-benefit calculation may favor proceeding with necessary dental work during denosumab therapy with aggressive preventive measures, as suggested by the Journal of the National Comprehensive Cancer Network 5